Scientific Media Resources
Learn more about how Bristol Myers Squibb is dedicated to developing and enhancing the safety and efficacy profiles of immune cell engagers for cancer therapy while propelling the pipeline forward.
Learn more about how understanding different types of treatment options for psoriasis can help patients work with their healthcare providers on the approach best suited to their needs.
Learn more about the Eosinophilic Esophagitis Histology Scoring System (EoEHSS) and how Bristol Myers Squibb is committed to increasing awareness and understanding of EoE.
Learn more about the endoscopic reference score, or the EREFS score, that is used by healthcare providers to help evaluate the severity of eosinophilic esophagitis (EoE).
Read more about our exploration into immune system pathways and the role they play in cancer growth.
- Signal regulatory protein α (SIRPα) >
- T-cell Immunoreceptor with Immunoglobulin and ITIM Domains >
- CC Chemokine Receptor 8 (CCR8) Immune Pathway >
- Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Pathway >
- Lysine-Specific Demethylase-1 (LSD1) Pathway >
- Colony-stimulating Factor 1 Receptor (CSF1R) Immune Pathway >
- Indoleamine 2,3-dioxygenase (IDO) Immune Pathway >
- Lymphocyte-Activation Gene 3 (LAG-3) Immune Pathway >
Learn about signal regulatory protein α (SIRPα) and how Bristol Myers Squibb is exploring the role SIRPα plays in cancer immunotherapy.
Learn more bromodomain and extraterminal domain (BET) proteins and how Bristol Myers Squibb is evaluating the effects of BET inhibitors in blood cancers and solid tumors.
Learn more about how researchers at Bristol Myers Squibb are exploring the tumor microenvironment to inform the development of new therapeutics.
Learn more about how clinical trials work and the critical role of diversity and inclusivity in medical research and drug development.
Learn about how healthcare professionals view early-stage cancer treatment and the potential of immunotherapy in earlier stages of cancer.
Learn how our comprehensive pipeline, spanning multiple approaches across platforms and modalities, sets us apart and enables us to fulfill our vision of transforming patients’ lives through science.
Learn about the science behind protein degradation and ongoing research that harnesses the power of this natural process.
Learn more about interleukins and how BMS researchers are investigating multiple ways of modulating an immune response to potentially decrease cancer growth.
Explore a timeline of developments in oncology and hematology.
Discover how cell therapies are unlocking new potential in cancer research.
Learn about the biomarkers under investigation in rheumatoid arthritis (RA).
Learn more about our exploration of pathways and the role they play in immune-mediated diseases.
Understand the Cytokine Storm and its Role in COVID-19
See how researchers are leveraging technologies like single cell RNA sequencing.
Learn about the role of medicinal chemistry in small molecule drug discovery.
Watch how researchers are harnessing the power of the innate immune system to investigate new ways of fighting cancer.
Explore emerging biomarkers currently under investigation in Immuno-Oncology research.
Learn how digital pathology helps us to better understand disease biology.
Learn about IO-ICON, a collaboration of health care professionals, scientists and industry working to provide patients with access to innovative Immuno-Oncology research in their communities.
Learn more about resistance to immunotherapy and new research evaluating these mechanisms.
Learn how we’re advancing cancer research through collaboration.
Learn more about our research in cardiovascular disease.
Learn about IBD GAPPS, a global survey initiative seeking to uncover emerging and under-recognized unmet needs for clinicians, patients and the wider community of inflammatory bowel disease (IBD) stakeholders.
Bristol Myers Squibb is studying the impact on survivorship throughout the continuum of cancer care with the goal of improving quality of survival in cancer.